|
|
|
41
|
A732H
|
PATADAY 0.2% EYE DR (NVS) OLOPATADI (C)
|
OLOPATADINE
|
PATADAY
|
2.5ML
|
C
|
25.36
|
25.362
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5202
|
ANTIALLERGIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIALLERGIC AGENTS
|
|
|
|
|
41
|
A732L
|
OLOPATADINE 0.2% EYE DR (FSB)
|
OLOPATADINE
|
OLOPATADINE
|
2.5ML
|
A
|
7.58
|
7.5841
|
BOTT
|
1
|
BOTT
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5202
|
ANTIALLERGIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIALLERGIC AGENTS
|
|
|
|
|
40
|
A741L
|
AAP-MEFLOQUINE 250MG TAB (APO/COL) MEFLOQUINE
|
MEFLOQUINE
|
AAP-MEFLOQUINE
|
8'S
|
A
|
15.39
|
1.92
|
TABLET
|
8
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
083008
|
ANTIMALARIALS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
A741N
|
AAP-MEFLOQUINE 250MG TAB (APO) MEFL
|
MEFLOQUINE
|
AAP-MEFLOQUINE
|
8'S
|
A
|
15.68
|
1.9606
|
TAB
|
8
|
BOX
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
083008
|
ANTIMALARIALS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIMALARIALS
|
|
|
|
|
40
|
A7512
|
SANDOSTATIN 0.1MG/ML INJ (NVS/COL) OCTREOTIDE
|
OCTREOTIDE
|
SANDOSTATIN
|
5X1ML
|
BQ
|
174.52
|
34.90
|
INJECTION
|
0
|
AMP
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9292
|
OTHER THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
A7512
|
SANDOSTATIN 0.1MG/ML INJ (NVS) OCTREOTID (BQ)
|
OCTREOTIDE
|
SANDOSTATIN
|
5X1ML
|
BQ
|
174.52
|
34.9033
|
AMP
|
20
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9292
|
OTHER THERAPEUTIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
OTHER THERAPEUTIC AGENTS
|
|
|
|
|
40
|
A7513
|
SANDOSTATIN LAR 20MG INJ (NVS/COL) OCTREOTIDE
|
OCTREOTIDE
|
SANDOSTATIN LAR
|
20MG VIAL
|
BQ
|
3,860.02
|
3,860.02
|
INJECTION
|
0
|
VIAL
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9292
|
OTHER THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
A7513
|
SANDOSTATIN LAR 20MG INJ (NVS) OCTREOTID (BQ)
|
OCTREOTIDE
|
SANDOSTATIN LAR
|
20MG VIAL
|
BQ
|
3860.02
|
3860.0201
|
VIAL
|
20
|
VIAL
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9292
|
OTHER THERAPEUTIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
OTHER THERAPEUTIC AGENTS
|
|
|
|
|
40
|
A751D
|
OCTREOTIDE 0.1MG/ML INJ (DIL/AHI)
|
OCTREOTIDE
|
OCTREOTIDE
|
10X1ML
|
BQ
|
24.55
|
2.46
|
INJECTION
|
0
|
VIAL
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9292
|
OTHER THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
A751L
|
OCTREOTIDE 0.1MG/ML INJ (CHC) (BQ)
|
OCTREOTIDE
|
OCTREOTIDE
|
1ML AMP
|
BQ
|
12.5
|
12.5043
|
AMP
|
20
|
AMP
|
CHC
|
CARITAS HEALTHCARE PVT LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
9292
|
OTHER THERAPEUTIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV/SC
|
6
|
OTHER THERAPEUTIC AGENTS
|
|
|
|
|
40
|
A7718
|
APO-QUETIAPINE 100MG TAB (APO/COL)
|
QUETIAPINE
|
APO-QUETIAPINE
|
100'S
|
BP
|
27.73
|
0.28
|
TABLET
|
30
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A771Q
|
QUETIDIN 100MG TAB (ABB/PHA) QUETIAPINE
|
QUETIAPINE
|
QUETIDIN
|
30'S
|
BP
|
13.40
|
0.45
|
TABLET
|
30
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A771Q
|
QUETIDIN 100MG TAB (ABB/PHA) QUETIAPINE (BP)
|
QUETIAPINE
|
QUETIDIN
|
30'S
|
BP
|
13.4
|
0.4467
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
6
|
ATYPICAL ANTIPSYCHOTICS
|
2023-03-07
|
|
|
|
40
|
A771S
|
SEROQUEL 100MG TAB (AZN/COL) QUETIAPINE
|
QUETIAPINE
|
SEROQUEL
|
30'S
|
C
|
38.36
|
1.28
|
TABLET
|
30
|
TAB
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-05-17
|
2024-03-31
|
Add to Contract as Cat C
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-05-17
|
|
|
|
41
|
A771S
|
SEROQUEL 100MG TAB (AZN) QUETIAPINE (C)
|
QUETIAPINE
|
SEROQUEL
|
30'S
|
C
|
38.36
|
1.2785
|
TAB
|
42
|
BOX
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ATYPICAL ANTIPSYCHOTICS
|
|
|
|
|
40
|
A771V
|
QUETIAPINE 100MG TAB (MCP/AHI)
|
QUETIAPINE
|
QUETIAPINE
|
3X10
|
BP
|
3.83
|
0.13
|
TABLET
|
30
|
TAB
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A771V
|
QUETIAPINE 100MG TAB (MCP) (BP)
|
QUETIAPINE
|
QUETIAPINE
|
3X10
|
BP
|
3.75
|
0.125
|
TAB
|
42
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ATYPICAL ANTIPSYCHOTICS
|
|
|
|
|
41
|
A771Y
|
APO-QUETIAPINE 100MG TAB (APO) (BP)
|
QUETIAPINE
|
APO-QUETIAPINE
|
100'S
|
BP
|
13.02
|
0.1302
|
TAB
|
42
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ATYPICAL ANTIPSYCHOTICS
|
|
|
|
|
40
|
A7726
|
APO-QUETIAPINE 200MG TAB (APO/COL)
|
QUETIAPINE
|
APO-QUETIAPINE
|
100'S
|
BP
|
33.71
|
0.34
|
TABLET
|
0
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A772AJ
|
QUEL 200MG SR TAB (IPC) QUETIAPINE XR (BP)
|
QUETIAPINE XR
|
QUEL
|
30'S
|
BP
|
6.74
|
0.2247
|
TABSR
|
0
|
BOX
|
IPC
|
IPCA Laboratories Ltd.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ATYPICAL ANTIPSYCHOTICS
|
|
